Back
iShares Genomics Immnlgy & Hlthcr ETF Vs. SPDR® S&P Pharmaceuticals ETF Industry Stock Comparison
Buy
63
IDNA
iShares Genomics Immnlgy & Hlthcr ETF
Last Price:
23.40
Seasonality Move:
6.61%
Buy
52
XPH
SPDR® S&P Pharmaceuticals ETF
Last Price:
40.18
Seasonality Move:
3.57%
Buy
63
iShares Genomics Immnlgy & Hlthcr ETF (IDNA)
is a Buy
Is iShares Genomics Immnlgy & Hlthcr ETF a Buy, Sell or Hold?
- The current iShares Genomics Immnlgy & Hlthcr ETF [IDNA] share price is $23.79. The Score for IDNA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- IDNA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
SPDR® S&P Pharmaceuticals ETF (XPH)
is a Buy
Is SPDR® S&P Pharmaceuticals ETF a Buy, Sell or Hold?
- The current SPDR® S&P Pharmaceuticals ETF [XPH] share price is $40.03. The Score for XPH is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- XPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IDNA Stock Price Chart
What is iShares Genomics Immnlgy & Hlthcr ETF's stock price today?
-
The iShares Genomics Immnlgy & Hlthcr ETF share price today is $23.79
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IDNA is experiencing selling pressure, which indicates risk of future bearish movement.
XPH Stock Price Chart
What is SPDR® S&P Pharmaceuticals ETF's stock price today?
-
The SPDR® S&P Pharmaceuticals ETF share price today is $40.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XPH is experiencing selling pressure, which indicates risk of future bearish movement.
IDNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 50.65 | Buy |
| Chaikin Money Flow: | -32818 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.48 - 24.32) | Sell |
| Bollinger Bands (100): | (22.79 - 24.29) | Buy |
XPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 43.99 | Sell |
| Chaikin Money Flow: | -13603 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.01 - 40.83) | Sell |
| Bollinger Bands (100): | (40.03 - 43.49) | Sell |
IDNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.55 | Buy |
| 20-day SMA: | 23.81 | Sell |
| 50-day SMA: | 23.46 | Buy |
| 200-day SMA: | 22.2 | Buy |
| 8-day EMA: | 23.69 | Buy |
| 20-day EMA: | 23.76 | Buy |
| 50-day EMA: | 23.65 | Buy |
| 200-day EMA: | 23.18 | Buy |
XPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.05 | Sell |
| 20-day SMA: | 40.32 | Sell |
| 50-day SMA: | 40.33 | Sell |
| 200-day SMA: | 40.56 | Sell |
| 8-day EMA: | 40.17 | Sell |
| 20-day EMA: | 40.31 | Sell |
| 50-day EMA: | 40.65 | Sell |
| 200-day EMA: | 41.07 | Sell |
iShares Genomics Immnlgy & Hlthcr ETF Earnings Growth & IDNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SPDR® S&P Pharmaceuticals ETF Earnings Growth & XPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
iShares Genomics Immnlgy & Hlthcr ETF Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
SPDR® S&P Pharmaceuticals ETF Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||